Cannabidiol and Its Effects on Patients with COVID-19 Infection

Yuval Kuntzman1, Gilad Halpert2, Howard Amital3

  • 1Zabludowicz Center for Autoimmune Diseases, Sheba Medical Center, Tel Hashomer, Israel, Internal Medicine B, Sheba Medical Center, Tel Hashomer, Israel.

Abstract

Insights

Cannabidiol (CBD) improved clinical outcomes for patients with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). While CBD showed promise, its impact on specific inflammatory cytokines requires further investigation.

Area of Science:

  • Immunology and Virology
  • Pharmacology and Therapeutics

Background:

  • Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) disease progression is significantly modulated by inflammatory cytokines.
  • Cannabidiol (CBD) is recognized for its immunomodulatory properties, suggesting potential therapeutic applications.

Purpose of the Study:

  • To evaluate the efficacy of cannabidiol (CBD) in patients diagnosed with SARS-CoV-2.
  • To quantify the impact of CBD on key serum inflammatory cytokine levels in SARS-CoV-2 patients.

Main Methods:

  • A double-blind, placebo-controlled study design was employed.
  • Sublingual CBD extract was administered to seven SARS-CoV-2 patients, with three receiving a placebo.
  • Clinical outcomes and serum cytokine concentrations were compared between the treatment and placebo groups.

Main Results:

  • Patients treated with sublingual CBD demonstrated improved clinical outcomes compared to the placebo group.
  • Serum cytokine levels exhibited differences between groups, but with inconsistent trends.
  • The study involved a small sample size (7 CBD, 3 placebo).

Conclusions:

  • Sublingual administration of CBD was associated with better clinical outcomes in SARS-CoV-2 patients versus placebo.
  • Observed clinical improvements did not consistently correlate with changes in the selected serum cytokines.
  • Further research is warranted to elucidate the precise mechanisms and clinical significance of CBD in SARS-CoV-2 management.

Related Concept Videos

Chemotherapy-Induced Nausea and Vomiting: Cannabinoids01:21

Chemotherapy-Induced Nausea and Vomiting: Cannabinoids

Tetrahydrocannabinol (THC) is a phytocannabinoid that primarily interacts with the CB1 receptor, a type of G protein-coupled receptor (GPCR) predominantly in and around the chemoreceptor trigger zone (CTZ) and emetic center. THC also blocks the serotonin receptor activity in the dorsal vagal complex (DVC) by inhibiting serotonin release. THC exerts its anti-emetic effects through these interactions, which are beneficial for patients undergoing chemotherapy.
Two synthetic agonists of THC,...
192
CNS Stimulants: Cocaine, Amphetamines and Cannabinoids01:24

CNS Stimulants: Cocaine, Amphetamines and Cannabinoids

CNS stimulants, such as cocaine, amphetamines, and cannabinoids, have varying structures and mechanisms of action that lead to different therapeutic effects and side effects. Cocaine, with its molecular formula C17H21NO4, is a tropane alkaloid and a tertiary amino compound. It has two chemical forms: the hydrochloride salt and the "freebase." The former is in powder form, while the latter involves removing the hydrochloride salt to create a form that can be smoked. Cocaine exerts its...
142
Controls in Experiments01:13

Controls in Experiments

When conducting an experiment, it is crucial to have control to reduce bias and accurately measure the dependent variables. It also marks the results more reliable. Controls are elements in an experiment that have the same characteristics as the treatment groups but are not affected by the independent variable. By sorting these data into control and experimental conditions, the relationship between the dependent and independent variables can be drawn. A randomized experiment always includes a...
6.9K
COPD: Management Using Bronchodilators and Corticosteroids01:26

COPD: Management Using Bronchodilators and Corticosteroids

Chronic obstructive pulmonary isease (COPD) involves a group of progressive lung disorders characterized by persistent airflow limitation and chronic respiratory symptoms. Asthma-COPD Overlap Syndrome (ACOS), encompassing features of both asthma and Chronic obstructive pulmonary disease (COPD), is a group of progressive lung disorders that includes chronic bronchitis, emphysema, and refractory (non-reversible) asthma. ACOS leads to complex clinical presentations that combine the inflammatory...
148
Anxiolytic Drugs: Benzodiazepines and Buspirone01:29

Anxiolytic Drugs: Benzodiazepines and Buspirone

Benzodiazepines are a class of anxiolytic drugs known for their rapid efficacy and high therapeutic-to-lethal dose ratio, but with a potential risk of drug dependence. These drugs are lipophilic, allowing for rapid absorption after oral administration, eventually reaching the central nervous system (CNS). Once in the CNS, benzodiazepines bind to the allosteric site of the GABAA receptor. This binding enhances the inhibitory effects of the neurotransmitter GABA. By doing so, they prevent...
389